Kudos to our partners at Rentschler Biopharma who recently celebrated their new state-of-the-art production line, formerly known as the Rentschler Biopharma Manufacturing Center, in Milford, MA. Now operational, the expansion is the largest in the company’s 150+ year history. Rentschler Biopharma acquired the Milford site in 2019. Since then, they have transformed the facility into a multi-product manufacturing site, expanding it from 93,000 square feet to 138,000 square feet in total. The company is a two-time awardee of the MLSC's Tax Incentive program, receiving more than $1.7 million toward the creation of 115 jobs.
Massachusetts Life Sciences Center
Government Administration
Waltham, Massachusetts 9,545 followers
The capital of scientific revolution.
About us
The Massachusetts Life Sciences Center (MLSC) is an economic development and investment agency dedicated to supporting the growth and development of the life sciences in Massachusetts, home to the most verdant and productive life sciences ecosystem in the world. Through public-private funding initiatives, the MLSC supports innovation, research & development, commercialization, and manufacturing activities in the fields of biopharma, medical device, diagnostics, and digital health. Since its creation in 2007, the MLSC has strategically deployed over $700 million in Massachusetts, through a combination of grants, loans, capital infrastructure investments, tax incentives, and workforce programs. These investments have created thousands of jobs and propelled the development of new therapies, devices, and scientific advancements that are improving patient health and well-being in Massachusetts and beyond.
- Website
-
http://www.masslifesciences.com
External link for Massachusetts Life Sciences Center
- Industry
- Government Administration
- Company size
- 11-50 employees
- Headquarters
- Waltham, Massachusetts
- Type
- Government Agency
- Founded
- 2007
- Specialties
- life sciences, grants, biotech, economic development, medical device, tax incentives, investment, workforce pipeline, biomanufacturing, internships, capital investment, innovation economy, and big data
Locations
-
Primary
1075 Main St
100
Waltham, Massachusetts 02451, US
Employees at Massachusetts Life Sciences Center
-
David Hendren
Executive Leader | Early & Growth Stage Entrepreneur | Board Director | Strategic Advisor | Venture and Private Equity Investor
-
Stuart Abelson
-
Pam Randhawa
CEO | BOD: Massbio, MLSC, Hercules Capital | Biotechnology | Diagnostics | Digital Health
-
Kristina Cates
Outreach, Education, and Curriculum Design
Updates
-
“When people think about life sciences in the United States, they think of Massachusetts.” A tremendous morning for our ecosystem in Framingham, MA. Today, the Healey-Driscoll Administration announced $13.1 million in grants through the MLSC’s STEM Equipment and Professional Development Grant program and the Workforce Development Capital Grant program. Secretary of Economic Development Yvonne Hao joined Senate President Karen Spilka, the MLSC team, and state and local officials to announce the awards at Sanofi in Framingham. Following today’s grant announcement, state and local officials toured Sanofi’s award-winning digitally enabled manufacturing facility in Framingham, one of the world’s first digital facilities using intensified, continuous production technologies. Read more on the announcement here: https://lnkd.in/eiUyh2gg
-
Kudos to our partners at the Ragon Institute of Mass General, MIT, and Harvard which recently celebrated the official opening of its new headquarters in Cambridge. The new building will support the Institute’s research to harness the power of the human immune system to prevent and cure disease. It continues to be a privilege to partner on and support the Ragon Institute Summer Experience (RISE) internship program which engages high school and undergraduate students underrepresented in medical research who are interested in learning about immunology and related fields. Read more on the new space here: https://ow.ly/7JgA50SuM3x
-
Last Wednesday was another momentous day for our ecosystem with the opening of Moderna’s state-of-the-art global headquarters in Cambridge, MA. According to the company, this new space serves as a central hub, showcasing Moderna’s dedication to science, sustainability, and innovation. Massachusetts Governor Maura Healey, Lt. Governor Kim Driscoll, and Economic Development Secretary Yvonne Hao were on-hand for the celebration of the cutting-edge 460,000 sq. ft. facility.
-
+1
-
Our partners at the Advanced Research Projects Agency for Health (ARPA-H) are seeking proposals from small businesses with the expertise to conduct innovative research and development. Small businesses and entrepreneurial organizations can register now to join the Investor Catalyst Hub’s information session tomorrow, Tuesday, July 2, at 1 p.m. ET. Program Managers will discuss their topics and time will be reserved for Q&A. Register today: https://ow.ly/T57a50StFjy Join the growing health innovation network of the Investor Catalyst Hub. Submit your spoke application today: https://ow.ly/I2Ih50Sthuu
-
The Mass Leads Act aims to strengthen Massachusetts’ global leadership and expand opportunity in our state now and for a generation to come. Massachusetts Biomedical Initiatives (MBI), a key anchor to Central Massachusetts and the entire Commonwealth's life sciences ecosystem, has been supported by the MLSC enabling MBI to triple the capacity of the incubator’s facility, expand its workforce programming, and advance its cluster building activities. The next iteration of the Life Sciences Initiative can help ensure the benefits of the life sciences continue to be shared across Massachusetts. #WhyMassLeads #WhyLifeSciences
-
From our MLSC family to yours, Happy Pride! The strongest ecosystem is a diverse one. During #PrideMonth and every day, we are grateful for the contributions of the LGBTQI+ community to the life sciences, our Commonwealth, and our nation.
-
📢 Program deadline approaching The MLSC's MassNextGen Initiative is designed to support underrepresented entrepreneurs by providing them with a year-long customized package of support, which includes non-dilutive grant funding and access to a network of seasoned professionals from the life sciences ecosystem helping them to refine their business strategies and effectively raise capital. The program is accepting applications until this Friday, June 14, 2024. Learn more: https://ow.ly/ItPx50Shnwv
-
It's always a privilege to represent Team Massachusetts to local, national, and global audiences. It was a spectacular #BIO204 for the MLSC team. Special thanks to MassBio and our partners in industry and government for helping demonstrate why our Commonwealth is the global life sciences hub. The countdown is on for #BIO2025 back in Boston. Learn more about why Massachusetts is the best place to discover, develop, and scale: https://ow.ly/p0eB50Sb9qW
-
Kudos to Lucy Therapeutics, who recently announced they raised $12.5 million in additional funding led by existing and new investors. The company is working to develop novel therapies based on mitochondrial small-molecule treatments and diagnostic biomarkers for complex neurological diseases. Lucy Therapeutics is a previous MassNextGen awardee. The MLSC initiative is designed to support underrepresented entrepreneurs by providing them with a year-long customized package of support, which includes non-dilutive grant funding and access to a network of seasoned professionals from the life sciences ecosystem helping them to refine their business strategies and effectively raise capital. The program is currently accepting applications until June 14, 2024 at 4 p.m. EST. Learn more about Lucy Therapeutics: https://lnkd.in/eq8m_DFA Learn more about MassNextGen: https://lnkd.in/eRrzK8X